Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A pharmacokinetic model for alpha interferon administered subcutaneously.

E Chatelut1, L Rostaing, N Grégoire

  • 1Institut Claudius-Regaud, Centre Hospitalier Universitaire, Toulouse, France.

British Journal of Clinical Pharmacology
|May 8, 1999
PubMed
Summary

This study models alpha interferon (alphaIFN) pharmacokinetics in hepatitis C patients, finding a limited sampling strategy can determine plasma AUC. Renal function impacts clearance, and body surface area affects distribution.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-cell proteomics reveals decreased abundance of proteostasis and meiosis proteins in advanced maternal age oocytes.

bioRxiv : the preprint server for biology·2024
Same author

Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs.

ESMO open·2023
Same author

Bioinspired gelatin/bioceramic composites loaded with bone morphogenetic protein-2 (BMP-2) promote osteoporotic bone repair.

Biomaterials advances·2022
Same author

Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves' disease to silent thyroiditis.

Journal of endocrinological investigation·2021
Same author

A microfluidic sperm-sorting device reduces the proportion of sperm with double-stranded DNA fragmentation.

Zygote (Cambridge, England)·2021
Same author

Predictive value of transcriptional expression of Krüppel-like factor-6 (KLF6) in head and neck carcinoma patients treated with radiotherapy.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2021

Area of Science:

  • Pharmacokinetics
  • Hepatology
  • Drug Metabolism

Background:

  • Alpha interferon (alphaIFN) is used to treat chronic hepatitis C virus infection.
  • Understanding alphaIFN pharmacokinetics is crucial for optimizing treatment efficacy.
  • Patient-specific factors may influence drug disposition.

Purpose of the Study:

  • To model alpha interferon (alphaIFN) pharmacokinetic profiles after subcutaneous injection.
  • To correlate pharmacokinetic parameters with patient demographic covariates.
  • To develop a limited sampling strategy for determining alphaIFN plasma area under the curve (AUC).

Main Methods:

  • Plasma alphaIFN pharmacokinetics were analyzed in 27 chronic hepatitis C patients (10 normal renal function, 17 haemodialysis).
  • Samples were assayed using Elisa; concentration-time data analyzed via population approach (NONMEM).

Related Experiment Videos

  • A one-compartment model with zero-order followed by first-order absorption best described the data.

    • Main Results:

    • Mean clearance in dialysis patients was 37% of that in normal renal function patients.
    • Volume of distribution significantly correlated with body surface area.
    • Bayesian analysis using NONMEM enabled individual plasma AUC determination from three samples within 24 hours.

    Conclusions:

    • The developed pharmacokinetic model facilitates obtaining individual AUC from limited sampling.
    • This strategy supports pharmacokinetic-pharmacodynamic analysis combining alphaIFN plasma concentrations and viraemic data.
    • The findings aid in personalized alphaIFN dosing and monitoring for hepatitis C treatment.